Furthermore, while we adjusted our models for the presence of diabetes mellitus, we did not have data available on the severity of diabetes and the use of insulin or oral hypoglycemic agents, which are factors that can affect systemic metabolism and therefore influence the association between metabolomics and exacerbation incidence. This evidence concerns the gene INS and diabetes mellitus.